BLTE — Belite Bio Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareMid Cap
- $2.34bn
- $2.25bn
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 25.6 | 17.3 | 42.1 | 88.2 |
Net Total Receivables | 0.04 | 0.023 | 0.019 | 0.867 |
Prepaid Expenses | ||||
Total Current Assets | 25.7 | 17.4 | 42.8 | 89.9 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.046 | 0.094 | 1.35 | 1.3 |
Other Long Term Assets | ||||
Total Assets | 25.7 | 18.3 | 44.3 | 94.6 |
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.972 | 1.64 | 2.1 | 3.63 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.972 | 1.64 | 2.77 | 4.21 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 24.8 | 16.7 | 41.5 | 90.4 |
Total Liabilities & Shareholders' Equity | 25.7 | 18.3 | 44.3 | 94.6 |
Total Common Shares Outstanding |